SCM
CNMD icon

Sterling Capital Management’s CONMED CNMD Stock Holding History

Sterling Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.3K Sell
621
-412
-40% -$14.8K ﹤0.01% 1876
2026
Q1 		$36.5K Sell
1,033
-763
-42% -$31K ﹤0.01% 1775
2025
Q4 		$72.9K Sell
1,796
-362
-17% -$15.7K ﹤0.01% 1649
2025
Q3 		$101K Buy
2,158
+1,316
+156% +$68.2K ﹤0.01% 1523
2025
Q2 		$43.9K Buy
842
+809
+2,452% +$44.4K ﹤0.01% 1541
2025
Q1 		$1.99K Buy
33
+2
+6% +$129 ﹤0.01% 2606
2024
Q4 		$2.12K Sell
31
-1
-3% -$70 ﹤0.01% 2770
2024
Q3 		$2.3K Buy
+32
New +$2.26K ﹤0.01% 2123

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Sterling Capital Management's CNMD Position: Q2 2026 in Review

Sterling Capital Management reduced its CONMED (CNMD) stake by 40% in Q2 2026, selling an estimated $14.8K and leaving 621 shares worth $20.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1876.

Sterling Capital Management first reported a position in CNMD in Q3 2024 and has held it in 8 quarters since. The position peaked at $101K in Q3 2025. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Sterling Capital Management held 621 shares of CONMED worth $20.3K as of Q2 2026.
  • Sterling Capital Management sold 412 CONMED shares in Q2 2026, an estimated $14.8K.
  • CONMED made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1876 holding.
  • Sterling Capital Management first reported a position in CONMED in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's CONMED position peaked at $101K in Q3 2025.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.